Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists

Objective To explore the factors influencing adoption of the sentinel lymph node (SLN) technique for endometrial cancer staging among gynecologic oncologists. Methods A self-administered, web-based survey was sent via email (April 20 through May 21, 2017) to all members of European Society of Gynecologic Oncologists, International Gynecologic Cancer Society, and Society of Gynecologic Oncologists. Surgical and pathologic practices related to SLN and reasons for not adopting this technique were investigated. Results Overall, 489 attending physicians or consultants in gynecologic oncology from 69 countries responded: 201 (41.1%), 118 (24.1%), and 117 (23.9%) from Europe, the USA, and other countries, respectively (10.8% did not report a country). SLN was adopted by 246 (50.3%) respondents, with 93.1% injecting the cervix and 62.6 % using indocyanine green dye. The National Comprehensive Cancer Network SLN algorithm was followed by 160 (65.0%) respondents (USA 74.4%, Europe 55.4%, other countries 71.4%). However, 66.7% completed a backup lymphadenectomy in high-risk patients. When SLN biopsy revealed isolated tumor cells, 13.8% of respondents recommended adjuvant therapy. This percentage increased to 52% if micrometastases were detected. Among the 243 not adopting SLN, 50.2% cited lack of evidence and 45.3% stated that inadequate instrumentation fueled their decisions. Conclusions SLN with a cervical injection is gaining widespread acceptance for staging of endometrial cancer among gynecologic oncologists worldwide. Standardization of the surgical approach with the National Comprehensive Care Network algorithm is applied by most users. Management of isolated tumor cells and the role of backup lymphadenectomy for ‘high-risk’ cases remain areas of investigation.

[1]  Matthew P. Goetz,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[2]  Kathleen R. Cho,et al.  Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  F. Ghezzi,et al.  Adoption of Minimally Invasive Surgery and Decrease in Surgical Morbidity for Endometrial Cancer Treatment in the United States. , 2018, Obstetrics and gynecology.

[4]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[5]  J. Boggess,et al.  Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. , 2017, Gynecologic oncology.

[6]  A. Fader,et al.  Sentinel lymph node assessment in endometrial cancer: a systematic review and meta‐analysis , 2017, American journal of obstetrics and gynecology.

[7]  A. Ivanova,et al.  A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. , 2017, The Lancet. Oncology.

[8]  A. Weaver,et al.  Incorporating robotic-assisted surgery for endometrial cancer staging: Analysis of morbidity and costs. , 2016, Gynecologic oncology.

[9]  J. Ledermann,et al.  ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  A. Fader,et al.  Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer. , 2015, Gynecologic oncology.

[11]  W. Gotlieb,et al.  Sentinel lymph node procedure in endometrial cancer: A systematic review and proposal for standardization of future research. , 2015, Gynecologic oncology.

[12]  I. Sperduti,et al.  Surgical and oncological outcome of robotic surgery compared to laparoscopic and abdominal surgery in the management of endometrial cancer. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  M. Munsell,et al.  Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer , 2015, International Journal of Gynecologic Cancer.

[14]  A. Weaver,et al.  Lymphedema After Surgery for Endometrial Cancer: Prevalence, Risk Factors, and Quality of Life , 2014, Obstetrics and gynecology.

[15]  N. Abu-Rustum Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[16]  Anastasia Ivanova,et al.  Detection of Sentinel Nodes for Endometrial Cancer With Robotic Assisted Fluorescence Imaging: Cervical Versus Hysteroscopic Injection , 2013, International Journal of Gynecologic Cancer.

[17]  R. Barakat,et al.  Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. , 2013, Gynecologic oncology.

[18]  I. Christensen,et al.  MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. , 2013, Gynecologic oncology.

[19]  A. Bats,et al.  Complications of lymphadenectomy for gynecologic cancer. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  L. Haas,et al.  Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. , 2012, Gynecologic oncology.

[21]  R. Barakat,et al.  Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Barakat,et al.  Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Barakat,et al.  Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. , 2008, Gynecologic oncology.

[24]  Andrea Mariani,et al.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. , 2008, Gynecologic oncology.